1Nattel SN, Adrianzen L, Kessler EC. (2017) Congenital
Heart Disease and Neurodevelopment: Clinical Manifestations,
Genetics, Mechanisms, and Implications. Can J Cardiol.
12:1543-1555.
2Simmons MA, Brueckner M. (2017) The genetics of
congenital heart disease understanding and improving longterm
outcomes in congenital heart disease: a review for the general
cardiologist and primary care physician. Curr Opin Pediatr.
5:520-528.
3Cuneo BF. (2001) 22q11.2 deletion syndrome: Di-
George, velocardiofacial, and conotruncal anomaly face syndromes.
Curr Opin Pediatr. 5:465-472.
4Villafane J, Edwards TC, Diab KA. (2017) Development
of quality metrics for ambulatory care in pediatric patients with
tetralogy of Fallot. Congenit Heart Dis. 6:762-767.
5Pierpont ME, Basson CT, Benson DW. (2007) Genetic
basis for congenital heart defects: current knowledge: a scientific
statement from the American Heart Association Congenital
Cardiac Defects Committee, Council on Cardiovascular Disease
in the Young: endorsed by the American Academy of Pediatrics.
Circulation. 23:3015-3038.
6Swillen A, McDonald-McGinn D. (2015) Developmental
trajectories in 22q11.2 deletion. Am J Med Genet C Semin
Med Genet. 2:172-181.
7Chowdhury D, Gurvitz M, Marelli A. (2017) Development
of Quality Metrics in Ambulatory Pediatric Cardiology. J
Am Coll Cardiol. 5:541-555.
8Hartwell LP, Baker AL, Jenkins KJ, de Ferranti SD,
Saleeb SF. (2019) Experience participating in the American College
of Cardiology Quality NetworkTM: paediatric and adult
congenital cardiology collaborative quality improvement. Cardiol
Young. 1:59-66.
9Marino BS, Lipkin PH, Newburger JW. (2012) Neurodevelopmental
outcomes in children with congenital heart disease:
evaluation and management: a scientific statement from the
American Heart Association. Circulation. 9:1143-1172.